| abstract |
The invention relates to the triazolopyridine carboxamide derivatives of formula (I) in which: X is a hydrogen atom, a halogen atom, or a (C1-C6)alkyl, (C1-C6)alkoxy, halo(C1-C6)alkyl, S(O)mR", hydroxyl or cyano group, A is absent or else is a bond, an oxygen atom, a sulphur atom, an NR, C(O)NR' or SO2NR' group, a (C1-C2)alkylene group or a (C2)alkenyl group, R1 and R2 are, independently of one another, one or more groups selected from a hydrogen atom, a (C1-C6)alkyl group, a (C1-C6)alkoxy group, a (C3-C7)cycloalkyl group, a (C3-C7)cycloalkyl(C1-C6)alkyl group, a (C3-C7)cycloalkyl(C1-C6)alkoxy group, a halogen atom, a cyano group, a C(O)R'. C(O)OR', C(O)NR10R20 or NO2 group, or an NR10R20 or NR10C(O)-R20 group, the (C1-C6)alkyl and (C1-C6)alkoxy groups being optionally substituted with one or more atoms or groups selected, independently of one another, from halogen atoms and hydroxyl, amino or NR10R20 groups. Process for the preparation thereof and therapeutic use thereof. |